Jakarta: Chinese vaccine manufacturer Sinovac has confirmed that its COVID-19 vaccine is still effective against the Omicron variant.
Sinovac Vice President Weining Meng said the company is aware that several countries have already used the CoronaVac vaccine as a booster.
The company, he said, is still conducting research and evaluation on the effectiveness of CoronaVac as a booster.
Based on data from Chile, which is using CoronaVac as a booster, antibody levels increase significantly.
"Three doses actually increase T-cell response to fight the latest COVID-19 variant," Meng told an online media briefing on Tuesday, February 2, 2022.
"This booster is effective against the latest Covid-19 variant," said Meng.
According to Meng, Sinovac is currently also developing a COVID-19 vaccine that is specifically designed to protect against the Omicron variant.
"When this vaccine is available, we will immediately send it to Indonesia," said Meng.
Cek Berita dan Artikel yang lain di Google News
FOLLOW US
Ikuti media sosial medcom.id dan dapatkan berbagai keuntungan
